Razorpay becomes Indian’s latest tech unicorn thanks to new venture capital, sovereign wealth backing
Indian fintech Razorpay has become the country's latest unicorn after picking up $100m of venture capital and sovereign wealth fund financing.
Indian fintech Razorpay has become the country's latest unicorn after picking up $100m of venture capital and sovereign wealth fund financing.
Private equity major Genstar Capital is reportedly already out eyeing up to $10bn for a pair of new fundraises, less than two years after hauling in $7bn for its last round of capital raising.
Singapore-based consumer internet company Sea, whose New York-listed shares have soared by more than 400% this year, is looking to take advantage of that positive sentiment to raise around $2bn from a new equity offering.
In the week ending October 9th 2020, HFR reported that hedge funds posted mixed declines in September as investor risk tolerance fell over uncertainty regarding additional coronavirus spreading in Europe and the US, the ...Article
In the week ending October 9th 2020, HFR reported that hedge funds posted mixed declines in September as investor risk tolerance fell over uncertainty regarding additional coronavirus spreading in Europe and the US, the strength
The Bank of Japan has said that it will pay extra on the reserves it holds of banks that become more cost efficient or that merge. A similar policy could well be introduced in Europe
UK chancellor Rishi Sunak’s announcement that large UK companies would need to make climate related disclosures whether listed or private was a step towards an important principle — that corporate transparency is a public good,
Ascendas Real Estate Investment Trust has launched an offering of new shares, eyeing S$1.2bn ($891.6m) to fund acquisitions across the US, Europe and Asia Pacific.
Gland Pharma, a subsidiary of Chinese conglomerate Shanghai Fosun Pharmaceutical Group, has started bookbuilding for its Indian IPO, set to be the largest pharmaceutical listing in the country.
Coronavirus triggers borrowing spree by private equity managers From FT: Private equity managers are turning to specialist borrowing facilities to ensure their highly leveraged strategies can survive the coronavirus pandemic, but there are growing concerns
India’s Emcure Pharmaceuticals has returned to the loan market after four years, seeking a small amount of $34m.
In the week ending October 9th 2020, HFR reported that hedge funds posted mixed declines in September as investor risk tolerance fell over uncertainty regarding additional coronavirus spreading in Europe and the US, the strength
Pritzker Private Capital (PPC) has agreed to acquire Highline Aftermarket, the leading manufacturer of windshield wash fluids in the US and a portfolio company of The Sterling Group; and Warren Distribution, one of the largest
Shrieve Chemical Company, a portfolio company of Gemspring Capital, has acquired the styrene business unit and other assets of CLP Chemicals. Gemspring acquired Shrieve, a distributor of industrial chemicals, fluids, and specialty lubricants, in December
Brook & Whittle, a portfolio company of Snow Phipps, has agreed to acquire sister companies Innovative Labeling Solutions and Wizard Labels. Brook & Whittle is a Connecticut-headquartered manufacturer of pressure-sensitive labels, shrink labels and medical
BC Partners held a first close for its BC European Capital XI fund on €4bn in September.
Northern European growth investor Verdane has hired Nils Bouchet as an investment director in Denmark.